Hey kids! Ever heard of stocks? They're like tiny pieces of ownership in a big company. Sometimes, the price of a stock goes way down. One company, Iovance Biotherapeutics, has seen its stock price drop a lot recently. Let's see what's happening!
- Iovance makes medicine to help people with a serious skin disease called melanoma.
- Doctors are excited about their new medicine, Amtagvi.
- The company is losing money, but hopes to make lots of money soon.
- Investors are worried because Iovance is spending a lot of money.
| Fact | Number |
|---|---|
| Stock price drop in 3 months | ~60% |
| Stock price drop from 52-week high | ~77% |
| Projected Amtagvi sales by 2029 | >$800 million |
| Current market value | ~$1.2 billion |
| 2024 Operating Costs | $559 million |
